R&D | January 13, 2026
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The company previously completed a $150 million venture investment, acquisition, and recapitalization
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
The expansion includes a larger technical and service team and increased local procurement
The Signals Xynthetica solution brings AI-driven in-silico generation, predictive modeling, and experimental validation into a single, governed environment
The ChemiSphere app exemplifies how M-Trust technology transforms workflows into seamless digital experiences
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
